POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,009 | -50.3% | 601 | -32.5% | 0.00% | – |
Q2 2023 | $8,068 | -58.4% | 891 | -66.6% | 0.00% | – |
Q1 2023 | $19,410 | +2.2% | 2,670 | 0.0% | 0.00% | – |
Q4 2022 | $19,000 | -9.5% | 2,670 | 0.0% | 0.00% | – |
Q3 2022 | $21,000 | +16.7% | 2,670 | 0.0% | 0.00% | – |
Q2 2022 | $18,000 | -14.3% | 2,670 | 0.0% | 0.00% | – |
Q1 2022 | $21,000 | +40.0% | 2,670 | 0.0% | 0.00% | – |
Q4 2021 | $15,000 | – | 2,670 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |